Greenlight Biosciences Holdings Stock Last Dividend Paid
Greenlight Biosciences Holdings fundamentals help investors to digest information that contributes to Greenlight Biosciences' financial success or failures. It also enables traders to predict the movement of Greenlight Stock. The fundamental analysis module provides a way to measure Greenlight Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Greenlight Biosciences stock.
Greenlight |
Greenlight Biosciences Holdings Company Last Dividend Paid Analysis
Greenlight Biosciences' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, Greenlight Biosciences Holdings has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
All Next | Launch Module |
Greenlight Fundamentals
Return On Equity | -3.67 | |||
Return On Asset | -0.82 | |||
Operating Margin | (14.94) % | |||
Current Valuation | 90.5 M | |||
Shares Outstanding | 151.68 M | |||
Shares Owned By Insiders | 42.90 % | |||
Shares Owned By Institutions | 26.85 % | |||
Number Of Shares Shorted | 1.03 M | |||
Price To Book | 2.14 X | |||
Price To Sales | 41.41 X | |||
Revenue | 6.38 M | |||
Gross Profit | (87.22 M) | |||
EBITDA | (153.99 M) | |||
Net Income | (167.06 M) | |||
Cash And Equivalents | 44.13 M | |||
Cash Per Share | 0.36 X | |||
Total Debt | 80.48 M | |||
Debt To Equity | 2.30 % | |||
Current Ratio | 1.16 X | |||
Book Value Per Share | 0.14 X | |||
Cash Flow From Operations | (136.73 M) | |||
Short Ratio | 0.78 X | |||
Earnings Per Share | (1.12) X | |||
Target Price | 0.6 | |||
Number Of Employees | 10 | |||
Beta | 1.44 | |||
Market Capitalization | 45.43 M | |||
Total Asset | 148.6 M | |||
Retained Earnings | (420.64 M) | |||
Working Capital | 35.75 M | |||
Z Score | -6.71 | |||
Net Asset | 148.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
CEOs Directory Screen CEOs from public companies around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |